Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.
Not Applicable
Recruiting
- Conditions
- arterial fibrillation after cardiac surgery (nonvalvular disease)
- Registration Number
- JPRN-UMIN000021138
- Lead Sponsor
- ihon University school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
past of arrhythmia cardiogenic shock NYHA class IV congestive heart failure despite treatment sinus bradycardia at rest (<50/min) second -or third-degree AV block clinical hypothyroidism or hyperthyroidism Doctor's decision not to register to this regimen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cerebrovascular and hemorrhagic event within 60 days
- Secondary Outcome Measures
Name Time Method Hb,PT, APTT UCG(pericardial effusion)